SetPoint Starts Trial on Bioelectronic Therapy for Crohn’s Disease

SetPoint Starts Trial on Bioelectronic Therapy for Crohn’s Disease
SetPoint Medical, a biotech company developing therapies for inflammatory bowel diseases (IBD), announced that it is now evaluating safety and efficacy for its novel treatment for Crohn’s disease. The announcement was made by the gastroenterologists responsible for the trial at the annual “Advances in Inflammatory Bowel Diseases” clinical and research conference hosted by the Crohn’s & Colitis Foundation in Orlando, Florida.

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *